Zebra Capital Management’s Zimmer Biomet ZBH Stock Holding History

Zebra Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-9,005	Closed	-$932K	–	291
2016 Q1	$932K	Buy	9,005 +1,630	+22%	+$158K	0.37%	131
2015 Q4	$735K	Buy	7,375 +531	+8%	+$52K	0.41%	105
2015 Q3	$624K	Buy	+6,844	New	+$686K	0.39%	121

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Zebra Capital Management's ZBH Position: Q2 2016 in Review

Zebra Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2016, closing a stake of 9,005 shares — an estimated $932K sold.

Zebra Capital Management first reported a position in ZBH in Q3 2015 and held it in 3 quarters. The position peaked at $932K in Q1 2016. 765 funds tracked by Wall St. Rank hold ZBH as of Q2 2016.

Zebra Capital Management reported no remaining Zimmer Biomet position as of Q2 2016 after selling out during the quarter.
Zebra Capital Management sold 9,005 Zimmer Biomet shares in Q2 2016, an estimated $932K.
Zebra Capital Management first reported a position in Zimmer Biomet in Q3 2015 and held it in 3 quarters.
Zebra Capital Management's Zimmer Biomet position peaked at $932K in Q1 2016.
765 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2016.

Based on Zebra Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.